Daiichi eyes almost $15B in oncology sales by 2030 in ADC franchise push

May 11, 2026 11:35 AM EDT R&DPharma Dai­ichi eyes al­most $15B in on­col­o­gy sales by 2030 in ADC fran­chise push Ayisha Sharma News Reporter Dai­ichi Sankyo is bet­ting on its on­col­o­gy fran­chise to push it past 3 tril­lion Japan­ese yen ($19 bil­lion) in 2030 rev­enues. The drug­mak­er pub­lished a … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER